Asymmetric dimethylarginine and homocysteine in exudative age-related macular degeneration

Asymmetric dimethylarginine and homocysteine in exudative age-related macular degeneration

Introduction: The oxidative stress has been proposed as an important case of exudative age-related macular degeneration (E-ARMD). The aim of the present study was to investigate homocysteine (Hcy), asymmetric dimethylarginine (ADMA) and oxidized low-density lipoprotein cholesterol (Ox-LDL-C) levels,...

Full description

Bibliographic Details
Main Authors:	Alireza Javadzadeh, Amir Ghorbanihaghjo, Sima Mansouri, Nadereh Rashtchizadeh
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2015-11-01
Series:	Journal of Analytical Research in Clinical Medicine
Subjects:	Age related macular degeneration Oxidative stress Asymmetric dimethylarginine Homocysteine Oxidized Low-density Lipoprotein Cholesterol
Online Access:	http://journals.tbzmed.ac.ir/JARCM/Manuscript/JARCM-3-236.pdf

Similar Items

The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia—Review
by: Weronika Dymara-Konopka, et al.
Published: (2019-06-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Homocysteine & its metabolite homocysteine-thiolactone & deficiency of copper in patients with age related macular degeneration - A pilot study
by: Muthuvel Bharathselvi, et al.
Published: (2016-01-01)

Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension
by: You-Lin Tain, et al.
Published: (2016-12-01)

Nebivolol prevents the increase of asymmetric dimethylarginine and oxidants in hyperhomocysteinemic rats
by: Mustafa Ahmet Huyut
Published: (2019-01-01)

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients
by: Osama Tayeh, et al.
Published: (2011-06-01)

Mechanism of Cellular Oxidation Stress Induced by Asymmetric Dimethylarginine
by: Srinidi Mohan, et al.
Published: (2012-06-01)

Roles of Nitric Oxide and Asymmetric Dimethylarginine in Pregnancy and Fetal Programming
by: You-Lin Tain, et al.
Published: (2012-11-01)

Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-Kappa B Ligand in Exudative Age-Related Macular Degeneration
by: Amir Ghorbanihaghjo, et al.
Published: (2014-04-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Restoration of Asymmetric Dimethylarginine–Nitric Oxide Balance to Prevent the Development of Hypertension
by: You-Lin Tain, et al.
Published: (2014-07-01)

Effect of resistance training on plasma nitric oxide and asymmetric dimethylarginine concentrations in type I diabetic rats
by: Parivash Shekarchizadeh Esfahani, et al.
Published: (2013-01-01)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
by: Fernando Andrade, et al.
Published: (2012-09-01)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
by: M.B.P. Landim, et al.
Published: (2013-05-01)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
by: M.B.P. Landim, et al.
Published: (2013-10-01)

Asymmetric and symmetric dimethylarginine in patients presenting with risk factors for coronary heart disease
by: Ilic Marina, et al.
Published: (2012-10-01)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
by: Adem Atıcı, et al.
Published: (2019-10-01)

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Plasma asymmetric dimethylarginine in childhood asthma exacerbation
by: Adel S Bediwy, et al.
Published: (2018-01-01)

Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis
by: Maurício Batista Paes Landim, et al.
Published: (2009-05-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
by: Ibrahim Kocayigit, et al.
Published: (2020-03-01)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
by: Rhys B. Murphy, et al.
Published: (2016-05-01)

Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)
by: Jeremy A. Scott, et al.
Published: (2014-04-01)

Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
by: Elena Oliva-Damaso, et al.
Published: (2017-03-01)

Asymmetric dimethylarginine and NO metabolites in patients with acute and chronic coronary heart disease
by: A. S. Galyavich, et al.
Published: (2009-02-01)

Increased Circulatory Asymmetric Dimethylarginine and Multiple Organ Failure: Bile Duct Ligation in Rat as a Model
by: Jiunn-Ming Sheen, et al.
Published: (2014-03-01)

ASYMMETRIC DIMETHYLARGININE, THE PROMOTER FACTOR OF CARDIOVASCULAR PATHOLOGIES
by: Anamaria Vîlcea, et al.
Published: (2019-09-01)

Associations between Endogenous Dimethylarginines and Renal Function in Healthy Children and Adolescents
by: Urszula Godula-Stuglik, et al.
Published: (2012-11-01)

Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
by: Juraj Madaric, et al.
Published: (2017-07-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension
by: Sahar Gamil, et al.
Published: (2020-08-01)

Renin-Angiotensin System Inhibitors Reduce Serum Asymmetric Dimethylarginine Levels and Oxidative Stress in Normotensive Patients with Chronic Kidney Disease
by: Hideki Fujii, et al.
Published: (2014-02-01)

Asymmetric Dimethylarginine Plasma Levels and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients
by: Francesco Perticone, et al.
Published: (2012-10-01)

Plasma levels of catecholamines and asymmetric dimethylarginine levels as predictive values of mortality among hemodialysis patients
by: Dziedzic Marcin, et al.
Published: (2014-06-01)

Does the Inhibitory Action of Asymmetric Dimethylarginine (ADMA) on the Endothelial Nitric Oxide Synthase Activity Explain Its Importance in the Cardiovascular System? The ADMA Paradox
by: Dimitrios Tsikas
Published: (2017-07-01)

Pathophysiological Role of Adiponectin, Leptin and Asymmetric Dimethylarginine in the Process of Atherosclerosis
by: Koleva Daniela Iv., et al.
Published: (2016-12-01)

Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease
by: Maro Dragičević, et al.
Published: (2020-11-01)

Endothelin-1 and Nitric Oxide levels in exudative age-related macular degeneration
by: Yuksel Totan, et al.
Published: (2015-01-01)